Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions – New York Times


Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions
New York Times
Now the two companies behind the competing drugs have found common ground in keeping those prices so high: They are deploying new patents to prevent patients and insurers from getting two essentially generic versions of the drugs for less money.

and more »
Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions
New York Times
Now the two companies behind the competing drugs have found common ground in keeping those prices so high: They are deploying new patents to prevent patients and insurers from getting two essentially generic versions of the drugs for less money.

and more »

Leave a Reply

Your email address will not be published. Required fields are marked *